CCR2 Plays a Critical Role in Dendritic Cell Maturation: Possible Role of CCL2 and NF-κB

被引:83
作者
Jimenez, Fabio [1 ,2 ]
Quinones, Marlon P. [1 ,2 ]
Martinez, Hernan G. [1 ,2 ]
Estrada, Carlos A. [1 ]
Clark, Kassandra [1 ,2 ]
Garavito, Edgar [1 ]
Ibarra, Jessica [1 ]
Melby, Peter C. [1 ,2 ]
Ahuja, Seema S. [1 ,2 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
[2] S Texas Vet Hlth Care Syst, Audie L Murphy Div, Vet Adm Ctr Res AIDS & HIV Infect 1, San Antonio, TX 78229 USA
基金
美国国家卫生研究院;
关键词
REGULATORY T-CELLS; LEISHMANIA-MAJOR; LANGERHANS CELLS; TNF-ALPHA; IN-VIVO; GENE-EXPRESSION; TRANSCRIPTION FACTORS; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; CD40; LIGATION;
D O I
10.4049/jimmunol.0803494
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
We postulated that CCR2-driven activation of the transcription factor NF-kappa B plays a critical role in dendritic cell (DC) maturation (e.g., migration, costimulation, and IL-12p70 production), necessary for the generation of protective immune responses against the intracellular pathogen Leishmania major. Supporting this notion, we found that CCR2, its ligand CCL2, and NF-kappa B were required for CCL19 production and adequate Langerhans cell (LC) migration both ex vivo and in vivo. Furthermore, a role for CCR2 in upregulating costimulatory molecules was indicated by the reduced expression of CD80, CD86, and CD40 in Ccr2(-/-) bone marrow-derived dendritic cells (BMDCs) compared with wild-type (WT) BMDCs. Four lines of evidence suggested that CCR2 plays a critical role in the induction of protective immunity against L. major by regulating IL-12p70 production and migration of DC populations such as LCs. First, compared with WT, Ccr2(-/-) lymph node cells, splenocytes, BMDCs, and LCs produced lower levels of IL-12p70 following stimulation with LPS/IFN-gamma or L. major. Second, a reduced number of LCs carried L. major from the skin to the draining lymph nodes in Ccr2(-/-) mice compared with WT mice. Third, early treatment with exogenous IL-12 reversed the susceptibility to L major infection in Ccr2(-/-) mice. Finally, disruption of IL-12p70 in radioresistant cells, such as LCs, but not in BMDCs resulted in the inability to mount a fully protective immune response in bone marrow chimeric mice. Collectively, our data point to an important role for CCR2-driven activation of NF-kappa B in the regulation of DC/LC maturation processes that regulate protective immunity against intracellular pathogens. The Journal of Immunology, 2010, 184: 5571-5581.
引用
收藏
页码:5571 / 5581
页数:11
相关论文
共 80 条
[1]
Ahuja SS, 1999, J IMMUNOL, V163, P3890
[2]
Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania [J].
Al-Wabel, Mohammad A. ;
Tonui, Willy K. ;
Cui, Liwang ;
Martin, Samuel K. ;
Titus, Richard G. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06) :1060-1065
[3]
CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells [J].
Aliberti, J ;
Sousa, CRE ;
Schito, M ;
Hieny, S ;
Wells, T ;
Huffnagle, GB ;
Sher, A .
NATURE IMMUNOLOGY, 2000, 1 (01) :83-87
[4]
Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[5]
Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens [J].
Berberich, C ;
Ramírez-Pineda, JR ;
Hambrecht, C ;
Alber, G ;
Skeiky, YAW ;
Moll, H .
JOURNAL OF IMMUNOLOGY, 2003, 170 (06) :3171-3179
[6]
Transcription factors in the control of dendritic cell life cycle [J].
Bharadwaj, Arpita S. ;
Agrawal, Devendi K. .
IMMUNOLOGIC RESEARCH, 2007, 37 (01) :79-96
[7]
Dendritic cells and cytokines in human inflammatory and autoimmune diseases [J].
Blanco, Patrick ;
Palucka, A. Karolina ;
Pascual, Virginia ;
Banchereau, Jacques .
CYTOKINE & GROWTH FACTOR REVIEWS, 2008, 19 (01) :41-52
[8]
Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers [J].
Bonizzi, G ;
Bebien, M ;
Otero, DC ;
Johnson-Vroom, KE ;
Cao, YX ;
Vu, D ;
Jegga, AG ;
Aronow, BJ ;
Ghosh, G ;
Rickert, RC ;
Karin, M .
EMBO JOURNAL, 2004, 23 (21) :4202-4210
[9]
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344 [J].
Brodmerkel, CM ;
Huber, R ;
Covington, M ;
Diamond, S ;
Hall, L ;
Collins, R ;
Leffet, L ;
Gallagher, K ;
Feldman, P ;
Collier, P ;
Stow, M ;
Gu, XM ;
Baribaud, F ;
Shin, N ;
Thomas, B ;
Burn, T ;
Hollis, G ;
Yeleswaram, S ;
Solomon, K ;
Friedman, S ;
Wang, AL ;
Xue, CB ;
Newton, RC ;
Scherle, P ;
Vaddi, K .
JOURNAL OF IMMUNOLOGY, 2005, 175 (08) :5370-5378
[10]
Campbell EM, 1999, J IMMUNOL, V163, P2160